Moreover, using Annexin V labeling as a readout of early-stage apoptosis, EPZ-6438 and GSK-126 dose-dependently reverted the apoptosis-resistant phenotype of PAH-PASMCs (Figure 2D). This evidence concerns the gene ANXA5 and pulmonary arterial hypertension.